HR-7535 : Still Just a Bill

The "Prescription Drug Supply Chain Pricing Transparency Act" or H.R. 7535, is a bill that directs the Comptroller General of the United States to conduct a comprehensive study on compensation and payment structures within the prescription drug supply chain that are related to a drug's price. Key provisions of the bill include:

  • Study Mandate: Requires the Comptroller General to analyze the types, magnitudes, and prevalence of price-related compensation structures among various entities, including pharmacy benefit managers, Part D plan sponsors, drug wholesalers, pharmacies, manufacturers, and other related service providers.
  • Scope of Analysis: The study must cover business models, compensation structures, variations between affiliated and unaffiliated entities, potential conflicts of interest, trends in price-based compensation, factors driving the use of such structures, and other relevant issues.
  • Reporting: The Comptroller General must submit a report to Congress within two years of the bill's enactment, detailing the study's findings and providing recommendations for legislative and administrative actions.
The goal of this legislation is to increase transparency and understanding of how prescription drug prices are influenced by compensation and payment arrangements within the supply chain.

Action Timeline

Action DateTypeTextSource
2024-12-17CommitteeReferred to the Subcommittee on Health.House committee actions
2024-03-08CommitteeReferred to the Subcommittee on Health.House committee actions
2024-03-05IntroReferralReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.House floor actions
2024-03-05IntroReferralReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.House floor actions
2024-03-05IntroReferralIntroduced in HouseLibrary of Congress

Policy Area :

See Subjects

Related Bills

See Related Bills